News und Analysen

Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination

Chevron Corporation (NYSE: CVX) today announced the start of oil production from the Whale semi-submersible platform in the deepwater U.S. Gulf of Mexico. Chevron U.S.A. Inc., a wholly owned

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the 43^rd Annual J.P

Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its quarterly earnings conference call on Friday, January 31, 2025, at 11:00 a.m. ET (10:00 a.m. CT).

Mike Wirth, Chairman and CEO of Chevron Corporation (NYSE: CVX), will take part in the Goldman Sachs Energy, CleanTech & Utilities Conference 2025 on Wednesday, January 8, 2025, at 9:00 AM ET

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI^® (encorafenib) in combination with cetuximab (marketed as ERBITUX^®) and mFOLFOX6

NIKE, Inc. (NYSE:NKE) today reported fiscal 2025 financial results for its second quarter ended November 30, 2024.

• 
  Second quarter revenues were $12.4 billion, down 8 percent on a reported basis

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EST on Tuesday, February 4, 2025. The

Pfizer Inc. (NYSE:PFE) today provided its full-year 2025 guidance⁽¹⁾ and reaffirmed its October 29, 2024 full-year 2024 guidance⁽¹⁾. The accompanying presentation can be found at www.pfizer.com/inv

American Express Company (NYSE: AXP) plans to host a live audio webcast to discuss fourth quarter and full year 2024 financial results on Friday, January 24, 2025, at 8:30 a.m. (ET).